32nd week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160228398 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | 2016-08-11 |
20160228399 | PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER | 2016-08-11 |
20160228400 | COMPOSITIONS CAPABLE OF ENHANCING THERMOGENESIS AND USES THEREOF | 2016-08-11 |
20160228401 | METHODS OF TREATING MELANOMA | 2016-08-11 |
20160228402 | COMPOSITION CONTAINING LIGNAN COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER | 2016-08-11 |
20160228403 | AGENT FOR PREVENTING OR AMELIORATING RENAL DYSFUNCTION | 2016-08-11 |
20160228404 | THERAPEUTIC AGENT FOR DISEASE BASED ON INHIBITORY EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR | 2016-08-11 |
20160228405 | ORAL CANNABINOID FORMULATIONS | 2016-08-11 |
20160228406 | THERAPEUTIC AGENT FOR DISEASE BASED ON INHIBITORY EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR | 2016-08-11 |
20160228407 | NOVEL 1,2- BIS-SULFONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2016-08-11 |
20160228408 | Inhibitors of CD40-TRAF6 Interaction | 2016-08-11 |
20160228409 | Compositions and Methods for Pain Relief | 2016-08-11 |
20160228410 | AN ANTI-LEUKEMIC AGENT USEFUL FOR INDUCING DIFFERENTIATION IN MYELOID LEUKEMIA CELLS | 2016-08-11 |
20160228411 | KCNQ CHANNELS AS THERAPEUTIC TARGETS | 2016-08-11 |
20160228412 | NOVEL PYRAZOLE DERIVATIVE | 2016-08-11 |
20160228413 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY | 2016-08-11 |
20160228414 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2016-08-11 |
20160228415 | COMPOUNDS AND METHODS FOR TREATING INFLUENZA | 2016-08-11 |
20160228416 | METHODS FOR TREATING SEIZURE DISORDERS AND PAIN | 2016-08-11 |
20160228417 | COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER | 2016-08-11 |
20160228418 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | 2016-08-11 |
20160228419 | SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS | 2016-08-11 |
20160228420 | POLYETHYLENE GLYCOL-CONTAINING COMPOSITION | 2016-08-11 |
20160228421 | COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA COMPRISING A SULFONAMIDE COMPOUND AND ANOTHER DRUG | 2016-08-11 |
20160228422 | TARGETED PHARMACOLOGICAL CHAPERONES | 2016-08-11 |
20160228423 | Methods of Administering Pirfenidone Therapy | 2016-08-11 |
20160228424 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | 2016-08-11 |
20160228425 | COMPOSITIONS AND METHODS FOR TREATMENT OF GULF WAR ILLNESS | 2016-08-11 |
20160228426 | METHODS OF TREATING PRURITIC CONDITIONS MEDIATED THROUGH NON-HISTAMINERGIC MECHANISMS IN DIABETIC PATIENTS | 2016-08-11 |
20160228427 | NOVEL PIPERIDINE COMPOUND OR SALT THEREOF | 2016-08-11 |
20160228428 | METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN | 2016-08-11 |
20160228429 | CONTROLLED RELEASE HYDROCODONE FORMULATIONS | 2016-08-11 |
20160228430 | Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A Activity | 2016-08-11 |
20160228431 | METHODS FOR TREATING CANCER WITH TRKA RECEPTOR TYROSINE KINASE ANTAGONISTS | 2016-08-11 |
20160228432 | HETEROARYL PYRIDONE AND AZA-PYRODINE COMPOUNDS | 2016-08-11 |
20160228433 | INTRANASAL DHE FOR THE TREATMENT OF HEADACHE | 2016-08-11 |
20160228434 | TREATMENT OF DISEASES CAUSED BY ABNORMAL LYMPHOCYTE FUNCTION WITH AN HDAC6 INHIBITOR | 2016-08-11 |
20160228435 | Arylamide compounds and compositions and uses thereof | 2016-08-11 |
20160228436 | USE OF TYROSINE KINASE INHIBITOR IN CANCER TREATMENT | 2016-08-11 |
20160228437 | MIXED LINEAGE KINASE INHIBITORS AND METHOD OF TREATMENTS | 2016-08-11 |
20160228438 | AZA-PYRIDONE COMPOUNDS AND USES THEREOF | 2016-08-11 |
20160228439 | Method and Pharmaceutical Composition for use in the Treatment of Epilepsy | 2016-08-11 |
20160228440 | COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE | 2016-08-11 |
20160228441 | METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS | 2016-08-11 |
20160228442 | NITROGEN-CONTAINING BICYCLIC AROMATIC HETEROCYCLIC COMPOUND | 2016-08-11 |
20160228443 | PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF | 2016-08-11 |
20160228444 | NUCLEOSIDE ANALOGS AND USES THEREOF | 2016-08-11 |
20160228445 | 6-AMINO-PURIN-8-ONE COMPOUNDS | 2016-08-11 |
20160228446 | Combination Drug Therapy | 2016-08-11 |
20160228447 | METHOD OF TREATING CANCER | 2016-08-11 |
20160228448 | Solid Forms of Ceftolozane | 2016-08-11 |
20160228449 | METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER | 2016-08-11 |
20160228450 | NOVEL GLP-1 RECEPTOR MODULATORS | 2016-08-11 |
20160228451 | ROCK in Combination with MAPK Pathway | 2016-08-11 |
20160228452 | TREATMENT OF METABOLIC DISEASES BY INHIBTION OF HTR2A OR HTR3 | 2016-08-11 |
20160228453 | Prostaglandin F2Alpha and Analogues Thereof for Treating Atrophic Cutaneous Scarring | 2016-08-11 |
20160228454 | INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS | 2016-08-11 |
20160228455 | COMPLEXES OF ABIRATERONE ACETATE, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016-08-11 |
20160228456 | COMBINATION | 2016-08-11 |
20160228457 | METHOD FOR CANCER CELL REPROGRAMMING | 2016-08-11 |
20160228458 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | 2016-08-11 |
20160228459 | MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF | 2016-08-11 |
20160228460 | NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE | 2016-08-11 |
20160228461 | LIPID EXTRACTION PROCESSES | 2016-08-11 |
20160228462 | LIPID COMPOSITIONS | 2016-08-11 |
20160228463 | BORON-CONTAINING SMALL MOLECULES | 2016-08-11 |
20160228464 | COMPOSITIONS COMPRISING RIFABUTIN, CLARITHROMYCIN, AND CLOFAZIMINE AND USES THEREOF | 2016-08-11 |
20160228465 | Modified Saponins For the Treatment of Fungal Infections | 2016-08-11 |
20160228466 | Glutamate Dehydrogenase 1 Inhibitors and Methods of Treating Cancer | 2016-08-11 |
20160228467 | PEG OR PEG BLOCK COPOLYMER FOR TREATING COLORECTAL CANCER | 2016-08-11 |
20160228468 | METHOD FOR REDUCING THE INFLAMMATORY ACTIVITY OF A STEM CELL TRANSPLANT AND USE THEREOF | 2016-08-11 |
20160228469 | METHOD OF PREPARING AUTOLOGOUS CELLS AND METHODS OF USE FOR THERAPY | 2016-08-11 |
20160228470 | COMPOSITION COMPRISING NEURAL CELL AND ELASTIN-LIKE POLYPEPTIDE FOR TREATING PARKINSON'S DISEASE | 2016-08-11 |
20160228471 | METHODS OF TREATING ISCHEMIC SPASTICITY | 2016-08-11 |
20160228472 | THERAPEUTIC METHOD USING CARDIAC TISSUE-DERIVED PLURIPOTENT STEM CELLS | 2016-08-11 |
20160228473 | DEVICE AND METHOD FOR IMMUNOSUPPRESSANT-FREE TRANSPLANTATION, AND USAGE THEREOF | 2016-08-11 |
20160228474 | METHOD FOR PRODUCING AMNIOTIC MESENCHYMAL STROMAL CELL COMPOSITION, METHOD FOR CRYOPRESERVING THE SAME, AND THERAPEUTIC AGENT | 2016-08-11 |
20160228475 | CELLULAR EXTRACTS | 2016-08-11 |
20160228476 | METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS | 2016-08-11 |
20160228477 | METHOD FOR IMPROVING SKIN CONDITION OR ANTI-MICROORGANISMS OR ANTI-OXIDATION USING LACTOBACILLUS SAKEI MD HONEYSUCKLE | 2016-08-11 |
20160228478 | NOVEL LACTOBACILLUS PLANTARUM ISOLATED FROM LEAVES OF CAMELLIA SINENSIS | 2016-08-11 |
20160228479 | NOVEL LACTOBACILLUS PLANTARUM ISOLATED FROM LEAVES OF CAMELLIA SINENSIS | 2016-08-11 |
20160228480 | NOVEL LACTOBACILLUS PLANTARUM ISOLATED FROM LEAVES OF CAMELLIA SINENSIS | 2016-08-11 |
20160228481 | NUTRACEUTICAL COMPOSITION AND METHODS OF USE | 2016-08-11 |
20160228482 | TEA TREE OIL DELIVERY SYSTEM | 2016-08-11 |
20160228483 | METHOD FOR EXTRACTION AND CONCENTRATION OF ALKALOIDS USING DIMETHYL ETHER | 2016-08-11 |
20160228484 | TOMATO POWDER-BASED COMPOSITION | 2016-08-11 |
20160228485 | SKIN MEDICATING SYSTEM | 2016-08-11 |
20160228486 | EXTRACT OF AERIAL PARTS OF OATS | 2016-08-11 |
20160228487 | METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME | 2016-08-11 |
20160228488 | NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING | 2016-08-11 |
20160228489 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS | 2016-08-11 |
20160228490 | METHODS AND COMPOSITIONS FOR TREATING MUCUSAL TISSUE DISORDERS | 2016-08-11 |
20160228491 | THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF | 2016-08-11 |
20160228492 | INHIBITORS OF VALOSIN-CONTAINING PROTEIN AND METHODS OF USE | 2016-08-11 |
20160228493 | AMINOSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | 2016-08-11 |
20160228494 | MICROPARTICLES COMPRISING GNRH MADE BY PGSS | 2016-08-11 |
20160228495 | Targeting the EGFR-SGLT1 Interaction for Cancer Therapy | 2016-08-11 |
20160228496 | METHODS FOR TREATING HCV | 2016-08-11 |
20160228497 | NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS | 2016-08-11 |